British Society for Rheumatology

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1096/fj.201701455rr Cardiac fibroblast‐specific p38α MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin‐6 signaling mechanism
https://doi.org/10.1111/j.1699-0463.1997.tb00567.x TNF blockade in rheumatoid arthritis: Implications for therapy and pathogenesis
https://doi.org/10.1038/nrrheum.2017.81 Biologics registers in RA: methodological aspects, current role and future applications
https://doi.org/10.1007/bf00832000 Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies
https://doi.org/10.1046/j.1365-2613.1999.00129.x New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders
https://doi.org/10.1093/rheumatology/keh083 Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody
https://doi.org/10.1093/rheumatology/36.6.700 Life-threatening transient neonatal Behcet's disease [published erratum appears in Br J Rheumatol 1997 Sep;36(9):1032]
https://doi.org/10.1191/0961203302lu313rp Anti-DNA antibodies - overview of assays and clinical correlations
https://doi.org/10.1136/annrheumdis-2019-215200 Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosus
https://doi.org/10.1016/j.jaut.2019.102340 Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus
https://doi.org/10.1002/cpt.1194 A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self‐Administered Questionnaires
https://doi.org/10.1093/rheumatology/kep356 Rituximab as early therapy for pulmonary haemorrhage in systemic lupus erythematosus
https://doi.org/10.3899/jrheum.161040 Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study
https://doi.org/10.1016/s2255-5021(13)70003-8 Primary Sjögren's syndrome prevalence in a major metropolitan area in Brazil
https://doi.org/10.1093/rheumatology/kex521 Management of gout by UK rheumatologists: a British Society for Rheumatology national audit
https://doi.org/10.1186/s12969-018-0278-1 Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ
https://doi.org/10.1097/bor.0b013e32832c49f2 Advances in childhood vasculitis
https://doi.org/10.1007/s00296-017-3751-0 National variation in the composition of rheumatology multidisciplinary teams: a cross-sectional study
https://doi.org/10.1016/s1473-3099(21)00133-x Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy
https://doi.org/10.3899/jrheum.130704 American College of Rheumatology Criteria at Inception, and Accrual over 5 Years in the SLICC Inception Cohort
https://doi.org/10.1093/rheumatology/keu475 Ofatumumab: a novel treatment for severe systemic lupus erythematosus
https://doi.org/10.1111/aji.13090 Serum markers of B‐cell activation in pregnancy during late gestation, delivery, and the postpartum period
https://doi.org/10.4049/jimmunol.0902640 Secreted IgM Enhances B Cell Receptor Signaling and Promotes Splenic but Impairs Peritoneal B Cell Survival
https://doi.org/10.3899/jrheum.100322 Quantitative Power Doppler Ultrasonography Is a Sensitive Measure of Metacarpophalangeal Joint Synovial Vascularity in Rheumatoid Arthritis and Declines Significantly Following a 2-week Course of Oral Low-dose Corticosteroids
https://doi.org/10.1136/annrheumdis-2018-214102 Autoinflammation due to homozygous S208 MEFV mutation
https://doi.org/10.1093/rheumatology/kez163 The relationship between citations, downloads and alternative metrics in rheumatology publications: a bibliometric study
https://doi.org/10.1097/rhu.0000000000000522 The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis
https://doi.org/10.12659/msm.882109 Etanercept treatment in juvenile idiopathic arthritis: The Polish registry
https://doi.org/10.1093/rheumatology/keac205 Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies
https://doi.org/10.1093/rheumatology/keac295 The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs
https://doi.org/10.1002/eji.201344245 Exacerbated experimental arthritis in Wiskott–Aldrich syndrome protein deficiency: Modulatory role of regulatory B cells
https://doi.org/10.1136/annrheumdis-2014-eular.5546 SAT0532 Updated Eular Evidence-Based Recommendations for the Diagnosis of Gout
https://doi.org/10.1006/jaut.1998.0255 Differential Activities of Immunogenic Collagen Type II Peptides in the Induction of Nasal Tolerance to Collagen-Induced Arthritis
https://doi.org/10.1093/rheumatology/key326 Giant cell arteritis: new concepts, treatments and the unmet need that remains
https://doi.org/10.1093/qjmed/hcv002 How should specialist competencies in heart valve disease be recognized?
https://doi.org/10.1002/art.42722 Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile‐Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature
https://doi.org/10.1093/rheumatology/kead646 Systemic lupus erythematosus patients have unique changes in serum metabolic profiles across age associated with cardiometabolic risk
https://doi.org/10.1136/annrheumdis-2020-217725 Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive
https://doi.org/10.7861/clinmedicine.11-2-119 UK rheumatology consultant workforce provision 2007–9: results from the BSR/Arthritis Research UK Consultant Workforce Register
https://doi.org/10.1371/journal.pone.0186513 Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome
https://doi.org/10.1093/bjd/ljad347 British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023: a pragmatic update
https://doi.org/10.1093/rheumatology/keae178 Can complement activation be the missing link in antiphospholipid syndrome?
https://doi.org/10.1093/cei/uxae032 Dysregulated lipid metabolism networks modulate T-cell function in people with relapsing-remitting multiple sclerosis
https://doi.org/10.1016/s2665-9913(23)00238-2 Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial
https://doi.org/10.1136/annrheumdis-2024-eular.2854 AB1439 UPDATE OF THE EULAR POINTS TO CONSIDER FOR USE OF ANTIRHEUMATIC DRUGS IN REPRODUCTION, PREGNANCY AND LACTATION
https://doi.org/10.3399/bjgp.2023.0586 Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus
https://doi.org/10.1093/rheumatology/keae698 Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS)
https://doi.org/10.1136/ard-2023-223862 Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosis
https://doi.org/10.1007/s10067-020-05058-8 Capacity building for the provision of rheumatological services in sub-Saharan Africa
https://doi.org/10.1016/s2665-9913(24)00221-2 Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study
https://doi.org/10.1093/rheumatology/keaa526 Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope
https://doi.org/10.1093/rheumatology/keae096 Where are we now in biologic drugs for myositis?
https://doi.org/10.7861/clinmedicine.16-6-500 The national clinical audit for rheumatoid and early inflammatory arthritis
https://doi.org/10.1093/rheumatology/kead484 Occupational impacts of early inflammatory arthritis: results from the National Early Inflammatory Arthritis Audit
https://doi.org/10.1093/rheumatology/keae276 Psychological distress over 12 months post-diagnosis in an early inflammatory arthritis cohort
https://doi.org/10.1093/cei/uxae071 The immune landscape of the inflamed joint defined by spectral flow cytometry
https://doi.org/10.1093/rheumatology/keae571 Deep-learning CT imaging algorithm to detect usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease: association with disease progression and survival
https://doi.org/10.1093/rheumatology/keaf006 Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis
https://doi.org/10.1136/ard-2023-224071 Approach to vaccination in systemic lupus erythematosus on biological treatment
https://doi.org/10.1093/rheumatology/keac260 Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs
https://doi.org/10.1002/cti2.70012 Naturally acquired adaptive immunity to Streptococcus pneumoniae is impaired in rheumatoid arthritis patients
https://doi.org/10.1093/rheumatology/keaf057 Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patients
https://doi.org/10.1093/rheumatology/keae150 Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis
https://doi.org/10.1093/rheumatology/keae218 Executive summary: British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease
https://doi.org/10.1093/rheumatology/keae592 Contributors to organ damage in childhood lupus: corticosteroid use and disease activity
https://doi.org/10.1002/msc.1089 Osteoarthritis: Patient Expectations about Future Pain, Stiffness and Function
https://doi.org/10.1002/art.43058 Do We Need Distinct Pediatric Classification Criteria for Rheumatic Diseases That Affect Both Children and Adults?
https://doi.org/10.1093/rheumatology/keaf233 Trends in remission rates for rheumatoid arthritis in England and Wales: a population-level cohort study
https://doi.org/10.1093/rheumatology/keaf312 Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort study
https://doi.org/10.1093/eurpub/ckae144.328 Cohort retention in a pandemic response study: Lessons from the SIREN study
https://doi.org/10.1016/s2665-9913(25)00256-5 Revisiting safety and refining benefit of rituximab–belimumab combination for refractory SLE
https://doi.org/10.1016/s2665-9913(25)00283-8 Clinical phenotypes, classification, and long-term outcomes of childhood-onset Sjögren's disease into adulthood: a single-centre cohort study
https://doi.org/10.1002/art.1780390703 Deactivation of vascular endothelium by monoclonal anti–tumor necrosis factor α antibody in rheumatoid arthritis
https://doi.org/10.1073/pnas.91.7.2762 Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.
https://doi.org/10.1093/rheumatology/36.6.643 Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti- tumour necrosis factor-alpha (cA2) therapy
https://doi.org/10.1002/art.1780400323 Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage
https://doi.org/10.1046/j.1365-2249.1998.00485.x Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis
https://doi.org/10.1046/j.1365-2249.1997.2901181.x Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA)
https://doi.org/10.1093/rheumatology/36.3.353 Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients
https://doi.org/10.1016/s0041-1345(98)01365-7 Anti-tnfα therapy is useful in rheumatoid arthritis and crohn’s disease: analysis of the mechanism of action predicts utility in other diseases
https://doi.org/10.1111/j.1365-2249.1994.tb06594.x Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli
https://doi.org/10.1002/1529-0131(199907)42:7<1497::aid-anr25>3.0.co;2-# T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis–associated and nonassociated HLA–DR4 alleles
https://doi.org/10.1002/1529-0131(200009)43:9<2046::aid-anr16>3.0.co;2-8 Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint
https://doi.org/10.1002/1529-0131(199902)42:2<199::aid-anr1>3.0.co;2-1 Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins
Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4.
https://doi.org/10.1016/s0049-0172(95)80025-5 The etiopathogenesis of Sjögren's syndrome
https://doi.org/10.4049/jimmunol.165.1.139 Lipopolysaccharide Stimulates the Proliferation of Human CD56+CD3− NK Cells: A Regulatory Role of Monocytes and IL-10
https://doi.org/10.1023/a:1009229508096 Angiogenesis in arthritis: role in disease pathogenesis and as a potential therapeutic target
https://doi.org/10.1002/art.1780230309 Vertebral osteophyte formation in experimental disc degeneration
https://doi.org/10.1093/rheumatology/36.2.229 Long-term follow-up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients
https://doi.org/10.1038/sj.gt.3301012 IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response
https://doi.org/10.1136/ard.62.5.407 Diagnostic strategy for the assessment of rheumatoid vasculitis
https://doi.org/10.1046/j.1365-2567.1998.00568.x An anti‐inflammatory role for interleukin‐11 in established murine collagen‐induced arthritis
https://doi.org/10.4049/jimmunol.161.12.6681 Structural Basis of the gp120 Superantigen-Binding Site on Human Immunoglobulins
https://doi.org/10.1002/dmrr.341 A role for innate immunity in type 1 diabetes?
https://doi.org/10.1002/art.1780400304 Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blotting
https://doi.org/10.1136/ard.2004.022111 Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
https://doi.org/10.1093/rheumatology/36.1.120 Polyarthropathy, orbital myositis and posterior scleritis: an unusual adverse reaction to influenza vaccine
https://doi.org/10.1046/j.1365-2249.1998.00785.x Rodent models of arthritis: relevance for human disease
https://doi.org/10.1023/a:1006756518500 Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan